pd 98059 has been researched along with Neurilemoma in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattingly, RR | 1 |
| Kraniak, JM | 1 |
| Dilworth, JT | 1 |
| Mathieu, P | 1 |
| Bealmear, B | 1 |
| Nowak, JE | 1 |
| Benjamins, JA | 1 |
| Tainsky, MA | 1 |
| Reiners, JJ | 1 |
1 other study available for pd 98059 and Neurilemoma
| Article | Year |
|---|---|
The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines.
Topics: Apoptosis; Benzamides; Blotting, Western; Butadienes; Cell Line, Tumor; Cell Proliferation; Enzyme I | 2006 |